Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
HK Stock Market Move | Zhongji Innolight (03308) rose over 5% after JPMorgan Chase increased its holdings again, with the optical communication giant's earnings guidance surpassing expectations.
HK Stock Market Move | WH GROUP (00288) fell over 5% again; Smithfield reported a mid-term profit increase of over 17%. The company has recently postponed its mid-term performance report.
UBS: Downgrades CHINA TOWER (00788) target price to HKD 10, maintains "Neutral" rating
HK Stock Market Move | Zhongji Innolight (03308) rose over 5% after JPMorgan Chase increased its holdings again, with the optical communication giant's earnings guidance surpassing expectations.
HK Stock Market Move | WH GROUP (00288) fell over 5% again; Smithfield reported a mid-term profit increase of over 17%. The company has recently postponed its mid-term performance report.
UBS: Downgrades CHINA TOWER (00788) target price to HKD 10, maintains "Neutral" rating
RECOMMEND
